433
Participants
Start Date
March 31, 2010
Primary Completion Date
December 31, 2010
Study Completion Date
January 31, 2011
Nebivolol
5 mg, titrated to 20 mg, once daily oral administration
Placebo
5 mg or 20 mg once daily, oral administration
Forest Investigative Site 040, New York
Forest Investigative Site 024, Harleysville
Forest Investigative Site 029, Prince Frederick
Forest Investigative Site 038, Baltimore
Forest Investigative Site 011, Baltimore
Forest Investigative Site 025, Richmond
Forest Investigative Site 027, Salisbury
Forest Investigative Site 012, Hickory
Forest Investigative Site 013, Charleston
Forest Investigative Site 018, Mt. Pleasant
Forest Investigative Site 035, Greenville
Forest Investigative Site 022, Simpsonville
Forest Investigative Site 009, Atlanta
Forest Investigative Site 031, Augusta
Forest Investigative Site 014, Daytona Beach
Forest Investigative Site 026, Jacksonville
Forest Investigative Site 030, Orlando
Forest Investigative Site 033, Hialeah
Forest Investigative Site 017, Miami
Forest Investigative Site 028, Coral Gables
Forest Investigative Site 010, Miami
Forest Investigative Site 001, Fort Lauderdale
Forest Investigative Site 037, Fort Lauderdale
Forest Investigative Site 021, Montgomery
Forest Investigative Site 008, Foley
Forest Investigative Site 003, Memphis
Forest Investigative Site 023, Paw Paw
Forest Investigative Site 005, Florissant
Forest Investigative Site 032, Corpus Christi
Forest Investigative Site 039, Meridian
Forest Investigative Site 041, Las Vegas
Forest Investigative Site 004, Los Angeles
Forest Investigative Site 002, Long Beach
Forest Investigative Site 006, Chino
Forest Investigative Site 020, Temecula
Forest Investigative Site 007, Auburn
Lead Sponsor
Forest Laboratories
INDUSTRY